Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study.
<h4>Background</h4>Autotaxin (ATX) and its product lysophosphatidic acid (LPA) are considered to be involved in the development of liver fibrosis and elevated levels of serum ATX have been found in patients with hepatitis C virus associated liver fibrosis. However, the clinical role of s...
Enregistré dans:
Auteurs principaux: | Thomas Pleli, Daniel Martin, Bernd Kronenberger, Friederike Brunner, Verena Köberle, Georgios Grammatikos, Harald Farnik, Yolanda Martinez, Fabian Finkelmeier, Sandra Labocha, Nerea Ferreirós, Stefan Zeuzem, Albrecht Piiper, Oliver Waidmann |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f85ff14292e741c48d9e01f2f8ef19b1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
PNEUMONIA IN PATIENTS WITH LIVER CIRRHOSIS
par: R. V. Kazakova
Publié: (2013) -
Epidemiological and clinical characteristics of patients with liver cirrhosis
par: Ludmila Martínez Leyva, et autres
Publié: (2021) -
Epidemiological and clinical characteristics of patients with liver cirrhosis
par: Ludmila Martínez Leyva, et autres
Publié: (2021) -
Anticoagulation in Patients with Liver Cirrhosis (Literature Review)
par: E. S. Eniseeva
Publié: (2019) -
A Multidisciplinary Team Approach to the Treatment of Liver Cirrhosis
par: Zhang YR, et autres
Publié: (2021)